№ lp_1_2_52942
File format: docx
Character count: 24727
File size: 123 KB
Patient initiated follow-up (PIFU) outlines a process where patients can initiate follow-up appointments based on their symptoms or needs, with clear guidelines for clinicians on patient eligibility, communication, and monitoring during the follow-up pathway.
Year:
2021
Region / City:
Not specified
Topic:
Patient follow-up process
Document Type:
Standard Operating Procedure (SOP)
Issuing Organization:
Not specified
Author:
Kirstin Eadie
Target Audience:
Clinical and administrative staff, operational managers, BI team
Effective Period:
Not specified
Approval Date:
27th September 2021
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Organisation:
Canberra Health Services
Document type:
Guideline
Reference number:
CHS25/225
Jurisdiction:
Australian Capital Territory
Healthcare setting:
Public health services
Subject area:
Medication management
Professional scope:
Nursing and midwifery practice
Approved by:
Drug and Therapeutics Committee
Target professionals:
Registered nurses and registered midwives
Patient groups:
Adults, children 12 years or older, and selected medicines for children under 12 years
Exclusions:
Neonates, Special Care Nursery patients, Neonatal Intensive Care Unit patients
Regulatory framework:
Australian medicines scheduling (Schedules 2, 3, 4, and 8)
Content components:
Governance, safe use, documentation, approved medicine lists
Year:
2025
Region / city:
Netherlands
Topic:
Clinical Trials, Industry, Medicine
Document Type:
Agreement
Institution:
Nationale Federatie van Universitair Medische Centra (NFU), vereniging Samenwerkende Topklinische opleidingsZiekenhuizen (STZ), Vereniging Innovatieve Geneesmiddelen, Stichting Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis (NKI/AvL), Prinses Máxima Centrum voor Kinderoncologie, Associatie van Contract Research Organisaties in Nederland (ACRON)
Author:
Not specified
Target audience:
Sponsors, CROs, Research Institutions
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Context:
A template for clinical trial agreements between industry sponsors, academic and non-academic hospitals in the Netherlands, including protocols, financial arrangements, and data protection requirements.
Year:
2023-2025
Region / City:
N/A
Subject:
Tenure Review Process
Document Type:
Procedural Guide
Institution:
N/A
Author:
Michael Susi, Jessie Tong, Margaret Edsall, Angel Flesher, Eugenia Lean, Mary Boyce
Target Audience:
Faculty members undergoing tenure review
Period of Validity:
2023-2025
Approval Date:
N/A
Date of Modifications:
N/A
State:
New Jersey
Country:
United States
Issuing body:
New Jersey Department of Education, Division of Teaching and Learning Services
Legal reference:
N.J.A.C. 6A:8-2.1
Standards last adopted:
2020
Review process initiated:
May 2025
Subject area:
Career readiness, financial literacy, information literacy, key competencies
Education levels:
Kindergarten through Grade 12
Domains:
Career Readiness; Personal Financial Literacy; Information Literacy; Key Competencies and Skills
Document structure:
Framework, disciplinary concepts, developmental progressions, performance expectations by grade band, summary of changes
Type of document:
State educational standards framework
Year:
2020
Region / city:
N/A
Topic:
Network procedure correction
Document type:
Change Request
Organization:
3GPP
Author:
Mediatek Inc.
Target audience:
Technical experts and network engineers
Effective period:
N/A
Approval date:
2020-06-08
Modification date:
N/A
Release:
Rel-16
Work item code:
TEI16
Category:
F
Clauses affected:
5.5.2.3.5
Summary:
The change request proposes a correction to the handling of abnormal cases in network initiated detach procedures, specifically addressing synchronization issues between the network and UE.
Year:
2025
Region / city:
Zurich
Theme:
Oncology, Clinical Trials
Document Type:
Funding Proposal
Institution:
University of Zurich, CCCZ
Author:
N/A
Target Audience:
Researchers, Investigators, Clinical Trials Applicants
Validity Period:
2025
Approval Date:
N/A
Date of Changes:
N/A
Context:
Detailed proposal outline for a research funding call for investigator-initiated clinical trials in oncology, including project description, team structure, cost estimate, and timelines.
Year:
2021
Region / City:
Canberra
Subject:
Surgery, Postponement, Elective Surgery
Document Type:
Standard Operating Procedure
Organization:
Canberra Health Services
Author:
Policy Team
Target Audience:
Medical Officers, Registered Nurses, Management/Executive Officers
Period of Validity:
Not specified
Approval Date:
12 November 2021
Amendment Date:
Not specified
Related Policies:
Elective Surgery Access, Clinical Records Management, Informed Consent, Occupational Violence, Consumer Feedback Management
Evaluation:
Monthly reviews of all elective surgery postponements
Legislation:
Health Records (Privacy and Access) Act 1997, Human Rights Act 2019, Work Health and Safety Act 2011
References:
Elective Surgery Access and Management Policy (2021), Waiting Time and Elective Surgery Policy (2012), Elective Surgery Access Policy (2015)
Search Terms:
Postponement, Surgery, Elective, Rescheduling, Elective Waiting List
Contextual Description:
This is a procedural document outlining the steps and guidelines for hospital-initiated postponement and rescheduling of elective surgeries at Canberra Health Services.
Year:
2023
Region:
Western Australia
Type of document:
Structured Administration and Supply Arrangement (SASA)
Authority:
Chief Executive Officer of Health under Part 6 of the Medicines and Poisons Regulations 2016
Issuer:
Dr Andrew Robertson, Chief Health Officer, Department of Health WA
Practitioner:
Registered Pharmacists with approved training
Practice setting:
Registered community pharmacies in Western Australia
Approved activity:
Supply of Schedule 4 oral antibiotics for uncomplicated urinary tract infection
Approved medicines:
Nitrofurantoin, Trimethoprim
Target population:
Female patients aged 18–65 with uncomplicated UTI
Conditions:
Compliance with training, registration, clinical criteria, record-keeping, and regulatory requirements
Date issued:
24 July 2023
Contact:
Medicines and Poisons Regulation Branch, [email protected]
Note:
, Number 034/7-2023
Type of Document:
Clinical Trial Research Agreement
Jurisdiction:
Australia
Parties:
Institution and Organisation
Subject:
Investigator Initiated Study
Related Legislation:
Privacy Act 1988 (Cth); A New Tax System (Goods and Services Tax) Act 1999 (Cth)
Regulatory Authorities:
Therapeutic Goods Administration (TGA); National Health and Medical Research Council (NHMRC)
Applicable Guidelines:
ICH Good Clinical Practice (CPMP/ICH/135/95) as adopted by TGA
Scope:
Conduct of a clinical study in accordance with an approved Protocol
Key Roles:
Principal Investigator; Responsible Human Research Ethics Committee (HREC)
Confidentiality:
Protection of Confidential Information excluding Personal Information
Intellectual Property:
Allocation and definition of Background and Study-related Intellectual Property
Study Components:
Protocol; Investigator’s Brochure; Case Report Forms; Biological Samples; Investigational Product
Completion Criteria:
Database lock and provision of Essential Documents including HREC acknowledgment
Year:
2021
Region / City:
United Kingdom
Topic:
Healthcare, Patient Care
Document Type:
Standard Operating Procedure (SOP)
Institution:
NHS
Author:
National Health Service (NHS)
Target Audience:
Healthcare professionals
Period of Application:
Indefinite
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / City:
Sacramento, California
Theme:
Public Utilities Commission, Regulatory Procedures, Utility Applications
Document Type:
Resolution
Institution / Organization:
Public Utilities Commission of the State of California
Author:
Public Utilities Commission of the State of California
Target Audience:
Utility companies, legal and regulatory professionals, public servants
Period of Validity:
Ongoing
Approval Date:
February 5, 2026
Amendment Date:
Not specified
Year:
2026
Region / City:
University of the Witwatersrand, South Africa
Subject:
Human Research Ethics
Document Type:
Application Form
Institution:
Human Research Ethics Committee (Medical)
Target Audience:
Researchers seeking ethics waiver
Purpose:
Postgraduate or investigator-initiated research without active human participation
Submission Method:
Email to Medical Ethics Office
Requirements:
Completion of all sections, typed form, ethics training certificate attached
Data Collection:
Not permitted before ethics clearance
Study Categories:
Literature review, in vitro study, microbiology, environmental surveillance, public observation
Applicant Roles:
Principal Investigator, Co-Investigator, Supervisor, Applicant
Endorsements:
Department/Unit Head, Academic or Clinical Head approval required
Guidelines Reference:
Appendix to the HREC (Medical) Application Form
Year:
2026
Institution:
University of Memphis Cecil C. Humphreys School of Law
Document Type:
Form
Audience:
Law students
Purpose:
Approval of student-initiated pro bono projects
Requirements:
Compliance with Pro Bono Handbook, prior approval before service
Submission:
Individual or group submission with participant list
Supervisor:
Anticipated organization supervisor contact information required
Project Scope:
Description of direct legal services and pro bono qualification
Training:
Indicate if training will be provided
Additional Notes:
Space for extra comments
Year:
2018
Region / City:
Victoria, Australia
Topic:
Education, Community Development
Document Type:
Guidelines
Organization:
Adult, Community and Further Education (ACFE) Board
Author:
ACFE Board
Target Audience:
Registered Learn Local Providers, Adult Education Institutions
Period of Validity:
2018-2019
Approval Date:
Not specified
Date of Changes:
Not specified
Country:
New Zealand
City:
Christchurch
Institution:
Christchurch Hospital
Organisation:
Nursing Council New Zealand; Canterbury District Health Board
Document Type:
Clinical agreement
Subject:
Nurse-initiated radiology referrals for adult patients
Healthcare Field:
Radiology; Nursing practice
Authorising Roles:
Clinical Director / Chief of Service; Chief of Radiology; Director of Nursing
Target Audience:
Clinical Nurse Specialists; Senior Medical Officers; Registered Medical Officers; Charge Nurse Managers; Radiologists; MRTs; Radiology nursing staff
Applicable Staff:
Registered Nurses and Nurse Practitioners registered with the Nursing Council New Zealand
Scope:
Adult patients within the specified hospital service
Associated Policies:
Midwife, Nurse Practitioner and Nurse Initiated Radiology Referrals Policy; CDHB Radiation Safety Plan
Associated Forms:
Diagnostic Radiology Consultation Form (QF00294); Interventional Radiology Consultation Form (QF01157)
Training Requirement:
CDHB healthLearn Nurse Midwife Radiology Referrals programme
Legal Reference:
Radiation Protection Act
Oversight:
Clinical Director of the service; Chief of Radiology; Director of Nursing
Audit Requirement:
Annual audit of nurse-initiated radiology referrals
Approval Process:
Clinical Director / Chief of Service; Chief of Radiology; Director of Nursing
Agreement Owner:
Clinical Director of the service; Director of Nursing
Authoriser:
Chief of Radiology (Principal Licence Holder)
Date of Authorisation:
dd month 20xx
Note:
Year
Topic:
Suicide Prevention
Document Type:
Survey
Organization / Institution:
GLS
Target Audience:
Participants of GLS funded training activities
Duration:
6 or 12 months after initial training
Year:
2023
Region / city:
United States
Topic:
Training Evaluation
Document type:
Template
Institution:
Centers for Disease Control and Prevention
Author:
CDC Training and Evaluation Team
Target Audience:
Training developers, evaluators, and learners
Duration:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2024
Region / City:
California
Subject:
Occupational Safety and Health, State Program Evaluation
Document Type:
Report
Institution:
U.S. Department of Labor, Occupational Safety and Health Administration
Author:
U.S. Department of Labor Occupational Safety and Health Administration
Target Audience:
Government agencies, occupational safety professionals
Period of Action:
October 1, 2023 – September 30, 2024
Approval Date:
May 1, 1973
Program Certification Date:
August 19, 1977
Date of Last Revision:
N/A
Year:
2024
Region / City:
Brazil
Subject:
Human Rights
Document Type:
Report
Organization:
Inter-American Commission on Human Rights (IACHR)
Author:
IACHR
Target Audience:
Governments, human rights organizations, international bodies
Effective Period:
2024
Approval Date:
2024
Date of Changes:
Not specified
Year:
2025
Region / city:
European Union
Topic:
Pharmacovigilance, PSUR Follow-Up
Document Type:
Report
Organ / institution:
CMDh
Author:
Lead Member State
Target Audience:
Health authorities, pharmaceutical companies, regulatory bodies
Period of validity:
February 2025 onwards
Approval Date:
Not specified
Amendment Date:
Not specified